Exercise capacity affects quality of life in patients with pulmonary hypertension

Lung

Volumn 191, Issue 4, 2013, Pages 337-343

  Halank, Michael ^a   Einsle, Franziska ^b   Lehman, Stephanie ^a   Bremer, Hinrich ^c   Ewert, Ralf ^d   Wilkens, Heinrike ^e   Meyer, F Joachim ^f   Grünig, Ekkehard ^g   Seyfarth, Hans Jürgen ^h   Kolditz, Martin ^a   Wieder, Gesine ^b   Höffken, Gert ^a   Köllner, Volker ^e,i  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c Schwarzwald Baar Klinikum   (Germany)

^d UNIVERSITY OF GREIFSWALD   (Germany)

^e SAARLAND UNIVERSITY   (Germany)

^f Klinikum Harlaching   (Germany)

^g UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^h UNIVERSITY HOSPITAL LEIPZIG   (Germany)

ⁱ Klinik für Psychosomatische Medizin und Psychotherapie   (Germany)

Author keywords

6 Minute walk distance; Anxiety; Chronic thromboembolic pulmonary hypertension; Depression; Peak oxygen uptake; Pulmonary arterial hypertension; Quality of life

Indexed keywords

ADULT; AGED; ANXIETY DISORDER; ARTICLE; CARDIOPULMONARY EXERCISE TEST; CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION; DEPRESSION; EXERCISE; FEMALE; HEART RIGHT ATRIUM PRESSURE; HEART RIGHT VENTRICLE FAILURE; HUMAN; LUNG HEMODYNAMICS; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; OXYGEN CONSUMPTION; OXYGEN THERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY HYPERTENSION; QUALITY OF LIFE; SHORT FORM 36; WORLD HEALTH ORGANIZATION;

EID: 84880772446     PISSN: 03412040     EISSN: 14321750     Source Type: Journal    
DOI: 10.1007/s00408-013-9472-6     Document Type: Article

References (34)

1. Simonneau G, Robbins IM, Beghetti M, Channick RN, Delcroix M, Denton CP, et al. (2009) Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 54(1):S43-S54. doi: 10.1016/j.jacc.2009.04.012
2. Galiè N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, et al. (2009) Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 34(6):1219-1263. doi: 10.1183/09031936.00139009
3. Condliffe R, Kiely DG, Gibbs JSR, Corris PA, Peacock AJ, Jenkins DP, et al. (2009) Prognostic and aetiological factors in chronic thromboembolic pulmonary hypertension. Eur Respir J 33(2):332-337. doi: 10.1183/09031936. 00092008
4. Saouti N, de Man F, Westerhof N, Boonstra A, Twisk J, Postmus PE, et al. (2009) Predictors of mortality in inoperable chronic thromboembolic pulmonary hypertension. Respir Med 103(7):1013-1019. doi: 10.1016/j.rmed.2009.01.017
5. Wensel R, Opitz CF, Anker SD, Winkler J, Höffken G, Kleber FX, et al. (2002) Assessment of survival in patients with primary pulmonary hypertension: importance of cardiopulmonary exercise testing. Circulation 106(3):319-324. doi: 10.1161/01.CIR.0000022687.08568.2A
6. Cenedese E, Speich R, Dorschner L, Ulrich S, et al. (2006) Measurement of quality of life in pulmonary hypertension and its significance. Eur Respir J 28:808-815. doi: 10.1183/09037936.06.00130405
7. Grünig E, Lichtblau M, Ehlken N, Ghofrani HA, et al. (2012) Safety and efficacy of exercise training in various forms of pulmonary hypertension. Eur Respir J 40:84-92. doi: 10.1183/09031936.00123711
8. Grünig E, Ehlken N, Ghofrani A, Staehler G, et al. (2011) Effect of exercise and respiratory training on clinical progression and survival in patients with severe chronic pulmonary hypertension. Respiration 81:394-401. doi: 10.1159/000322475
9. Strange G, Keogh AM, Williams TJ, Wlodaeczyk J, McNeil K, Gabby E (2008) Bosentan therapy in patients with pulmonary arterial hypertension: the relationship between improvements in 6 minute walk distance and quality of life. Respirology 13:674-682. doi: 10.1111/j.1440-1843.2008.01326.x
10. Pepke-Zaba J, Beardsworth A, Chan M, Angalakuditi M (2009) Tadalafil therapy and health-related quality of life in pulmonary arterial hypertension. Curr Med Res Opin 25:2479-2485. doi: 10.1185/03007990903210066
11. Simonneau G, Rubin LJ, Galie N, Barst RJ, et al. (2008) Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension. Ann Intern Med 149:521-530
12. Chua R, Keogh AM, Byth K, O'Loughlin A (2006) Comparison and validation of three measures of quality of life in patients with pulmonary hypertension. Intern Med J 36(11):705-710. doi: 10.1111/j.1445-5994.2006.01169.x
13. Zlupko M, Harhay MO, Gallop R, Shin J, Archer-Chicko C, Patel R, et al. (2008) Evaluation of disease-specific health-related quality of life in patients with pulmonary arterial hypertension. Respir Med 102(10):1431-1438. doi: 10.1016/j.rmed.2008.04.016
14. Löwe B, Gräfe K, Ufer C, Kroenke K, Grünig E, Herzog W, et al. (2004) Anxiety and depression in patients with pulmonary hypertension. Psychosom Med 66(6):831-836. doi: 10.1097/01.psy.0000145593.37594.39
15. McCollister DH, Beutz M, McLaughlin V, Rumsfeld J, Masoudi FA, Tripputi M, et al. (2010) Depressive symptoms in pulmonary arterial hypertension: prevalence and association with functional status. Psychosomatics 51(4):339-347
16. McHorney CA, Ware JE, Lu JFR, Sherbourne CD (1994) The MOS 36-item short-form Health Survey (SF-36): tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 32(1):40-66. doi: 10.1097/00005650-199401000-00004
17. Bullinger M (1995) German translation and psychometric testing of the SF-36 Health Survey: preliminary results from the IQOLA project. Soc Sci Med 41(10):1359-1366. doi: 10.1016/0277-9536(95)00115-N
18. American Thoracic Society (2002) ATS Statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166(1):111-117. doi: 10.1164/rccm.166/1/111
19. Chemla D, Castelain V, Herve P, Lecarpentier Y, Brimioulle S (2002) Haemodynamic evaluation of pulmonary hypertension. Eur Respir J 20(5):1314-1331. doi: 10.1183/09031936.02.00068002
20. Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67(6):361-370. doi: 10.1111/j.1600-0447.1983.tb09716.x
21. Herrmann C, Buss U, Snaith R (1995) Hospital anxiety and depression scale (HADS-D) (German version). Huber, Bern
22. Hinz A, Schwarz R (2001) Angst und Depression in der Allgemeinbevö lkerung. Psychother Psychosom Med Psychol 51:193-200
23. Wensel R, Francis DP, Meyer FJ, Opitz CF, et al. (in press) Incremental prognostic value of cardiopulmonary exercise testing and resting haemodynamics in pulmonary arterial hypertension. Int J Cardiol. doi: 10.1016/j.ijcard.2012. 03.135
24. Looper KJ, Pierre A, Dunkley DM, Sigal JJ, Langleben D (2009) Depressive symptoms in relation to physical functioning in pulmonary hypertension. J Psychosom Res 66(3):221-225. doi: 10.1016/j.jpsychores.2008.09.014
25. Wittchen HU, Einsle F (2012) Depression, anxiety and somatic complaints - is it all psychosomatic? Medicographia 34(3):307-314
26. Wilkens H, Grimminger F, Hoeper M, Staehler G, Ehlken B, Plesnila-Frank C, et al. (2010) Burden of pulmonary arterial hypertension in Germany. Respir Med 104(6):902-910. doi: 10.1016/j.rmed.2010.01.002
27. Shafazand S, Goldstein MK, Doyle RL, Hlatky MA, Gould MK (2004) Health-related quality of life in patients with pulmonary arterial hypertension. Chest 126(5):1452-1459. doi: 10.1378/chest.126.5.1452
28. White J, Hopkins RO, Glissmeyer EW, Kitterman N, Elliott CG (2006) Cognitive, emotional, and quality of life outcomes in patients with pulmonary arterial hypertension. Respir Res 7(55):1-10. doi: 10.1186/1465-9921-7-55
29. Parry GD, Cooper CL, Moore JM, Yadegarfar G, Campbell MJ, Esmonde L, et al. (2012) Cognitive behavioural intervention for adults with anxiety complications of asthma: prospective randomised trial. Respir Med 106(6):802-810. doi: 10.1016/j.rmed.2012.02.006
30. Cuijpers P, Muñoz RF, Clarke GN, Lewinsohn PM (2009) Psychoeducational treatment and prevention of depression: the "coping with depression" course thirty years later. Clin Psychol Rev 29(5):449-458. doi: 10.1016/j.cpr.2009.04.005
31. Jonkers CCM, Lamers F, Bosma H, Metsemakers JFM, van Eijk JTM (2012) The effectiveness of a minimal psychological intervention on self-management beliefs and behaviors in depressed chronically ill elderly persons: a randomized trial. Int Psychogeriatr 24(2):288-297. doi: 10.1017/S1041610211001748
32. Rubenfire M, Lippo G, Bodini BD, Blasi F, Allegra L, Bossone E (2009) Evaluating health-related quality of life, work ability, and disability in pulmonary arterial hypertension: an unmet need. Chest 136(2):597-603. doi: 10.1378/chest.08-1260
33. Ganderton L, Jenkins S, McKenna SP, Gain K, Fowler R, Twiss J, Gabbay E (2011) Validation of the Cambridge pulmonary hypertension outcome review (CAMPHOR) for the Australian and New Zealand population. Respirology 16:1235-1240. doi: 10.1111/j.1440-1843.2011.02030.x
34. Cima K, Twiss J, Speich R, McKenna SP, Grünig E, Kähler CM, Ehlken N, Treder U, Crawford SR, Huber LC, Ulrich S (2012) The German adaptation of the Cambridge pulmonary hypertension outcome review (CAMPHOR). Health Qual Life 10:110. doi: 10.1186/1477-7525-10-110